US Patent Issued to Sumitomo Pharma Switzerland, Takeda Pharmaceutical on June 24 for "Treatment of prostate cancer" (California, North Carolina, Massachusetts Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,336,990, issued on June 24, was assigned to Sumitomo Pharma Switzerland GmbH (Basel, Switzerland) and Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Treatment of prostate cancer" was invented by Vijaykumar Reddy Rajasekhar (Apple Valley, Calif.), Brendan Mark Johnson (Chapel Hill, N.C.), David B. Maclean (Cambridge, Mass.), Lynn Seely (San Mateo, Calif.), Paul N. Mudd Jr. (Cary, N.C.) and Helene M. Faessel (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating prostate cancer, including advanced prostate cancer, in a subject in need thereof, include administering once-daily to the subject, at least 80 mg of N-(4-(1-(2,6-d...